AR061046A1 - Mirtazapina para el tratamiento del dolor neuropatico - Google Patents
Mirtazapina para el tratamiento del dolor neuropaticoInfo
- Publication number
- AR061046A1 AR061046A1 ARP070102181A ARP070102181A AR061046A1 AR 061046 A1 AR061046 A1 AR 061046A1 AR P070102181 A ARP070102181 A AR P070102181A AR P070102181 A ARP070102181 A AR P070102181A AR 061046 A1 AR061046 A1 AR 061046A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- neuropathic pain
- mirtazapine
- medicament
- administering
- Prior art date
Links
- 208000004296 neuralgia Diseases 0.000 title abstract 5
- 208000021722 neuropathic pain Diseases 0.000 title abstract 5
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 title 1
- 229960001785 mirtazapine Drugs 0.000 title 1
- RONZAEMNMFQXRA-MRXNPFEDSA-N esmirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)C[C@@H]2C2=CC=CC=C21 RONZAEMNMFQXRA-MRXNPFEDSA-N 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06114316 | 2006-05-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR061046A1 true AR061046A1 (es) | 2008-07-30 |
Family
ID=37006417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070102181A AR061046A1 (es) | 2006-05-22 | 2007-05-21 | Mirtazapina para el tratamiento del dolor neuropatico |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2026814A2 (https=) |
| JP (1) | JP2009537601A (https=) |
| AR (1) | AR061046A1 (https=) |
| CA (1) | CA2651607A1 (https=) |
| MX (1) | MX2008014287A (https=) |
| PE (1) | PE20080455A1 (https=) |
| TW (1) | TW200808804A (https=) |
| WO (1) | WO2007135123A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6452954B2 (ja) * | 2013-05-16 | 2019-01-16 | 国立大学法人千葉大学 | 癌転移抑制剤 |
| PL3261645T3 (pl) | 2015-02-27 | 2021-12-06 | Dechra Limited | Pobudzanie apetytu, zarządzanie utratą masy ciała, i leczenie anoreksji u psów i kotów |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6211171B1 (en) * | 1998-05-19 | 2001-04-03 | Dalhousie University | Use of antidepressants for local analgesia |
| RU2268725C2 (ru) * | 2000-01-19 | 2006-01-27 | Акцо Нобель Н.В. | Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных расстройств |
| US7074961B2 (en) * | 2000-09-26 | 2006-07-11 | The Brigham And Women's Hospital, Inc. | Antidepressants and their analogues as long-acting local anesthetics and analgesics |
| UA83666C2 (ru) * | 2003-07-10 | 2008-08-11 | Н.В. Органон | Способ получения энантиомерно чистого миртазапина |
| TW200538100A (en) * | 2004-04-21 | 2005-12-01 | Akzo Nobel Nv | Mirtazapine salts |
-
2007
- 2007-04-24 TW TW096114463A patent/TW200808804A/zh unknown
- 2007-05-18 PE PE2007000615A patent/PE20080455A1/es not_active Application Discontinuation
- 2007-05-21 CA CA002651607A patent/CA2651607A1/en not_active Abandoned
- 2007-05-21 EP EP07729316A patent/EP2026814A2/en not_active Withdrawn
- 2007-05-21 WO PCT/EP2007/054872 patent/WO2007135123A2/en not_active Ceased
- 2007-05-21 JP JP2009511495A patent/JP2009537601A/ja active Pending
- 2007-05-21 AR ARP070102181A patent/AR061046A1/es unknown
- 2007-05-21 MX MX2008014287A patent/MX2008014287A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2026814A2 (en) | 2009-02-25 |
| WO2007135123A2 (en) | 2007-11-29 |
| JP2009537601A (ja) | 2009-10-29 |
| PE20080455A1 (es) | 2008-06-25 |
| MX2008014287A (es) | 2008-11-18 |
| TW200808804A (en) | 2008-02-16 |
| CA2651607A1 (en) | 2007-11-29 |
| WO2007135123A3 (en) | 2008-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP21051833A (es) | Combinación de dextrometorfano y bupropión para el tratamiento de depresión | |
| CL2011002858A1 (es) | Uso de una composicion farmaceutica transmucosa oral que comprende dexmedetomidina y una sal farmaceuticamente aceptable y un excipiente farmaceuticamente aceptable para preparar un medicamento util para tratar o prevenir el dolor. | |
| UY35624A (es) | Uso de dosis elevadas de pridopidina para tratar la enfermedad de huntington | |
| CL2011000935A1 (es) | Composicion farmaceutica que comprende acetaminofeno y un material de tramadol complejo, que exhibe una liberacion sostenida y coordinada a traves de una capa de liberacion sostenida y otra de liberacion inmediata; metodo de preparacion;y el uso de un material complejo de tramadol y acetaminofeno para preparar un medicamento para el tratamiento del dolor. | |
| EA201300121A1 (ru) | Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения | |
| CO6160321A2 (es) | Uso de 2-6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro-2h-pirimidin-1-ilmetil-4-fluoro-benzonitrilo | |
| MX2009003372A (es) | Formas de dosificacion de pelicula no mucoadhesiva. | |
| MX2009002196A (es) | Oblea de buprenorfina para terapia de sustitucion de farmacos. | |
| AR060836A1 (es) | Un disco trans-mucosa para administrar un agente activo, una composicion trans-mucosa y el metodo de administracion obtenido | |
| AR065580A1 (es) | Mejoras en composiciones medicinales o relativas a las mismas | |
| CO6220969A2 (es) | Adminsitracion semanal de inhibidores de peptidasa de dipeptidilo | |
| UY30158A1 (es) | Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor | |
| AR065581A1 (es) | Mejoras en composiciones medicinales o relativas a las mismas | |
| MX367209B (es) | Una composición intravenosa que comprende ibuprofeno y paracetamol en combinación. | |
| AR089509A1 (es) | Metodo para tratar la perdida osea alveolar, un implante dental, un anticuerpo antiesclerostina, un gel o matriz que comprende dicho anticuerpo y uso | |
| MX2009011900A (es) | Curacion de herida diabetica. | |
| MX2022015629A (es) | Uso de vibegron para tratar vejiga sobreactiva. | |
| CL2009001841A1 (es) | Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto. | |
| AR065582A1 (es) | Mejoras en composiciones medicinales o relativas a las mismas | |
| AR065139A1 (es) | Medicamento para el tratamiento de la endometriosis | |
| ECSP10010567A (es) | Utilizacion de dronedarona para preparar un medicamento para el tratamiento de pacientes con arritmia y que tienen un incremento del nivel de creatinina debido a la administracion de dronedarona | |
| CL2008000965A1 (es) | Composicion farmaceutica que comprende un agente antiinflamatorio no esteroideo y un analgesico opiaceo, y su uso para el tratamiento del dolor. | |
| AR075866A1 (es) | Una dosis de ave5026 para el tratamiento de tromboembolismo venoso en pacientes con deterioro renal severo. uso. composicion farmaceutica. | |
| AR061046A1 (es) | Mirtazapina para el tratamiento del dolor neuropatico | |
| ES2325291A1 (es) | "uso de un extracto de silybum marianum" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |